KNOWLEDGE BANK

Interviews

Merck

Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshooting and technical training for downstream processes Chan holds a degree in Chemical Engineering from the National University of Singapore

Articles

Perspectives on the Vaccine Industry

Article talks about the key findings on the study conducted by Merck on the future of vaccine manufacturing in the AsiaPacific region

Research Insights

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

Biopharmaceutical products BPs are widely used to treat autoimmune diseases but immunogenicity limits their efficacy for an important proportion of patients Our knowledge of patientrelated factors influencing the occurrence of antidrug antibodies ADAs is still limited

Case Studies

Tablet Coating at Low Bed Temperatures with a Novel Coating Polymer

This study shows how to obtain elegant uniform coatings with zero visible defects and a practical coating solution for heat sensitive products For More Infromation Click Here

Techno Trends

Denovo Biopharma Launches First-in-Class Liafensine for Treating Depression

Denovo Biopharma has introduced DB a pioneering treatment for treatmentresistant depression Liafensine operates as a groundbreaking triple reuptake inhibitor aiming at serotonin

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Detangling the Diagnostic Odyssey in Neurodevelopmental Disorder by Genomic Consultancy

Emili Banerjee Bhattacharjee

Geneticist and Genetic Counselor, MFC Woman and Child Care, West Bengal, India

Koutilya Bhattacharjee

Assistant Professor, Department of Zoology; Ramakrishna Mission Vivekananda Centenary College, West Bengal, India

2

The Rapidly Evolving Landscape of Cancer Therapeutics

Rajesh Kumar

Assistant Professor of Pharmaceutical Sciences at Kerala University of Health Sciences

Seetha Harilal

Assistant Professor of Pharmacology at Kerala University of Health Sciences

3

Allosteric Modulation: A Paradigm Shift in Pharmaceutical Innovation

Dr. Parth Sarthi Sen Gupta

School of Biosciences and Bioengineering, D Y Patil International University (DYPIU).

4

APAC’s Rising Role in Neurodegenerative Disease Research and Development

Simona Lambertini

Senior Global Clinical Programs Lead & Independent Consultant

5

Meaningful Advances in Virtual Cells

Brita Belli

Senior Manager of Communications, Recursion

press releasesRead more...

Taimei Technology and C&R Research Announce Strategic Partnership to Build AI-Powered Clinical Trial Innovation

Taimei Technology HK a leading AIpowered drug clinical development platform company and CR Research A a toptier CRO in South Korea signed an enterpriselevel strategic partnership agreement

Cartography Biosciences Announces Strategic Investment From Samsung Ventures to Advance Oncology Pipeline

Cartography Biosciences and Samsung Ventures today announced a strategic investment to support the advancement of Cartographys differentiated oncology pipeline and expand its proprietary drug discovery platform

Waiv Enters Collaboration with Daiichi Sankyo to Deliver AI-Derived Biomarkers for ADC Program

Waiv formerly Owkin Dx a Parisbased company catalyzing AI precision testing today announced it has entered a collaboration with Daiichi Sankyo TSE to lead digital pathology biomarker discovery for an antibodydrug conjugate ADC program

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany

Vertex Pharmaceuticals Incorporated announced today that a reimbursement agreement was signed with the GKVSpitzenverband for its CRISPRCas geneedited therapy CASGEVY exagamglogene autotemcel This agreement secures sustainable access to this innovative

Cleveland Clinic, RIKEN, and IBM Model a 12,635-Atom Protein - the Largest Known to Be Simulated with Quantum Computers

Scientists at Cleveland Clinic RIKEN and IBM NYSE IBM have used IBM quantum computers and two of the worlds most powerful supercomputers to simulate protein complexes spanning up to atoms

INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases

INmune Bio Inc a clinicalstage biotechnology company and Anthony Nolan a pioneering UKbased charity that set up the worlds first stem cell register and is now driving forward cell therapy advancements

EventsRead more...

06 - 07

May 2026

06 - 07

May 2026

07 - 08

May 2026

10 - 14

May 2026

Respiratory Drug Delivery 2026

The Westin Kierland Phoenix, Arizona, USA

12 - 13

May 2026

14 - 14

May 2026

20 - 21

May 2026

20 - 21

May 2026

Pharma Partnering EU Summit 2026

Pharma Partnering Summit
Basel Marriott Hotel, Switzerland

LATEST NEWSRead more...

Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics

Roche announced today that it has entered into a definitive merger agreement to acquire PathAI a USbased company in digital pathology and AIpowered technology for pathology laboratories and the biopharma industry

Artera Receives U.S. FDA Clearance for ArteraAI Breast, Expanding Its AI Platform to Breast Cancer

Artera the developer of multimodal artificial intelligence MMAIbased prognostic and predictive cancer tests today announced US Food and Drug Administration FDA clearance of ArteraAI Breast for use in patients with earlystage

FUJIFILM Biosciences and NextCell Launch New Commercial Platform Comprised of RUO Stromal Cells and Cell Culture Media

FUJIFILM Biosciences a global leader in the life science market and NextCell Pharma AB a clinicalstage company specializing in cell therapy using umbilical cord mesenchymal stromal cells MSC today announced a global commercial launch resulting from their strategic collaboration

Merck Completes Acquisition of Terns Pharmaceuticals

Merck known as MSD outside the United States and Canada has completed the acquisition of Terns Pharmaceuticals

ZETA SURGICAL® Receives FDA 510(k) Clearance Expanding Access to Brain Tumor Biopsies, Hydrocephalus, and Trigeminal Neuralgia

Arrowhead Pharmaceuticals Inc has announced that Australias Therapeutic Goods Administration TGA has approved REDEMPLO plozasiran The medicine is a small interfering RNA siRNA therapy used alongside

CS Analytical Announces Major Laboratory Expansion

CS Analytical Laboratory has announced plans to expand its facility in Clifton New Jersey by doubling its current laboratory space The company is a cGMPcompliant FDAregistered and inspected contract laboratory focused on package and container